The next generation of MMP inhibitors: Design and synthesis

Annals of the New York Academy of Sciences

Volumn 878, Issue , 1999, Pages 40-60

  De, Biswanath ^a   Natchus, Michael G ^a   Cheng, Menyan ^a   Pikul, Stanislaw ^a   Almstead, Neil G ^a   Taiwo, Yetunde O ^a   Snider, Catherine E ^a   Chen, Longyin ^a   Barnett, Bobby ^a   Gu, Fei ^a   Dowty, Martin ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPROLACTAM; CGS 27023A; MARIMASTAT; MATRIX METALLOPROTEINASE INHIBITOR; PIPERAZINE DERIVATIVE; PRINOMASTAT; SULFONAMIDE;

CONFERENCE PAPER; DRUG DESIGN; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR WEIGHT;

EID: 0032798959     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07673.x     Document Type: Conference Paper

References (19)

1. 1. Birkedal-Hansen, H., W. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, J.A. Engler. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral. Biol. Med. 4: 197-250.
2. 2. Matrisian, L.M. 1990. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6: 212-125.
3. 3. Murphy, G. & A.J.P Docherty. 1992. The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell. Mol. Biol. 7: 120-125.
4. 4. Docherty, A.J.P. & G. Murphy. 1990. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann. Rheum. Dis. 49: 469-479.
5. 5. Woessner, F.J. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB 5: 2145-2154.
6. 6. Beckett, R.P., A.H. Davidson, A.H. Drummond, P. Huxley, & M. Whittaker. 1996. Drug Discovery Today 1: 16-26.
7. 7. Beckett, R. P. & M. Whittaker. 1998 Exp. Opin. Ther. Patents 8: 259-282.
8. 8. Henderson, B., A.J.P. Docherty, & N.R.A Beeley, 1990. Design of inhibitors of articular cartilage destruction. Drugs of the Future 15: 495-508.
9. 9. Williamson, R.A. et al. 1994. Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry 33: 11745-11759.
10. 10. Spurlino, J.C. et al. 1994. 1.56, a structure of mature truncated human fibroblast collagenase. Proteins: Structure, Function Genetics 19: 98-109.
11. 11. Browner, M.F. 1994. Matrix metalloproteases: structure-based drug discovery targets. Perspect. Drug Discovery Design 2: 343-351.
12. 12. Babine, R.E. & S.L. Bender. 1997. Molecular recognition of protein-ligand complexes: Applications to drug design. Chem. Rev. 97: 1359-1472.
13. 13. Natchus, M.G., M. Cheng, C.T. Wahl, S. Pikul, N.G. Almstead, R.S. Bradley, Y.O. Taiwo, G.E. Mieling, C.M. Dunaway, C.E. Snider, J.M. McIver, B.L. Barnett, S.J. McPhail, M.B. Anastasio & B. De. 1998. Design and synthesis of conformationally-constrained MMP inhibitors. Bioorg. Med. Chem. Lett. 16: 2077-2080.
14. 14. MacPherson, L.J. & D.T. Parker, inventor; Ciba-Geigy AG, assignee. 1993. European patent 0 606 046 A1. Date of application: June 1.
15. 15. Pikul, S. et al. 1998. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases, J. Med. Chem. Submitted for publication.
16. 16. De, B., M.G. Natchus, S. Pikul, N.G. Almstead, M. Cheng, et al., inventors; P&GP, assignee. 1996. World patent 9808825-AI. Date of application: August 28.
17. 17. Pikul, S., K.L. McDow Dunham, N.G. Almstead, B. De, M.G. Natchus, M.V. Anastasio, S.J. McPhail, C.E. Snider, Y.O. Taiwo, T. Rydel, C.M. Dunaway, F. Gu, & G.E. Mieling. 1998. Discovery of potent, achiral matrix metalloprotease inhibitors. J. Med. Chem. 41: 3568-3571.
18. 18. Pikul, S. et al., inventors; P&G, assignee. 1996. World patent 9808823-A1. Date of application: August 28.
19. 19. Kluender, H. et al., inventors; Bayer, assignee. 1995. World patent 96/15096. Date of application: November 15.